The United States Congress designated January as Cervical Health Awareness Month. Of all cancers that affect women, cervical cancer is one of the most preventable. The human papillomavirus (HPV) causes...

By

Just days after a joint committee in Kenya said the mass vaccination of tetanus is a safe program and should go on, the Kenya Conference of Catholic Bishops (KCCB) released a lengthy statement that concluded...

By

Johnson & Johnson (NYSE: JNJ) is pleased to announce the formation of consortia with leading global research institutions and non-government organizations to work in conjunction with Janssen Pharmaceutical...

By

A report published in the January 16 Morbidity and Mortality Weekly Report (MMWR) estimates that getting a flu vaccine this season reduced a person’s risk of having to go to the doctor because of flu...

By

Researchers at the University of Rochester Medical Center are testing a new oral vaccine to prevent infection with HIV, the virus that causes AIDS. The vaccine is unique because it is given as a pill,...

By

A new study by Baylor College of Medicine and Texas Children’s Hospital researchers shows that a vaccine for rotavirus in infants reduces the rates of infection. In the study of children enrolled in...

By

Preliminary data from Phase I clinical trials of two Ebola vaccines ̶ ChAd3-ZEBOV vaccine, being developed by GlaxoSmithKline, and rVSV-ZEBOV vaccine, being developed by NewLink Genetics and Merck Vaccines...

By

The World Health Organization (WHO) has given it’s stamp of approval for the use of the meningitis group A vaccine, MenAfriVac® in infants in Sub-Sahara Africa. In the four years since its introduction...

By

The measles vaccines have been some of the most scrutinized vaccines concerning safety and adverse events in recent years. Now a 12-year study of two types of measles-containing vaccines, published Monday...

By

Bavarian Nordic A/S announced today the initiation of a Phase 1, first-in-human clinical trial of the preventative Ebola vaccine regimen consisting of MVA-BN® Filo and the AdVac® technology from Crucell...